Related Articles
Anti‑PD‑1 immune checkpoint inhibitor inducing endocrine toxicity in a patient with advanced lung cancer: A case report and literature review
Isolated adrenocorticotropic hormone deficiency potentially induced by nivolumab following pseudo‑progression in clear cell renal cell carcinoma: A case report
Safety and tolerability of PD-1/PD-L1 inhibitors in elderly and frail patients with advanced malignancies
Cytokine release syndrome and immune effector cell‑associated neurotoxicity syndrome in a melanoma patient treated with adjuvant pembrolizumab
Proton beam therapy combined with retrograde intra‑arterial infusion chemotherapy for an extremely rapid growing recurrent ameloblastic carcinoma: A case report